retatrutide combination therapy ♥️Introducing (“RETA”) — a next-level advancement in medical weight management! Retatrutide uniquely combines two GLP-1 receptor agonists into one powerful treatment, designed to maximize results and support sustainable weight goals. This What is Retatrutide treatment: Boost

for insured patients, co-pays are dictated by plan tiers

[...] PSM statement on deeply concerning compounding of GLP-1 weight-loss pills PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug

It's not yet FDA approved, but could be by 2027

Last reviewed: June 6, 2026 Last updated: June 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations